As for our study, each pattern was preferentially observed in specific glioma subtypes and we were able to confirm that the absence of p16 expression was significantly correlated with worse outcomes in all glioma samples, including IDH-mutant gliomas. This evidence concerns the gene CDKN2A and central nervous system cancer.